New heat-activated gel could boost liver cancer therapy
NCT ID NCT07356531
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new gel that hardens at body temperature to block blood flow to liver tumors during chemoembolization. About 216 adults with liver cancer will receive either the new gel or standard gelatin sponge particles. The goal is to see if the new gel better controls tumor growth.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Cancer Hospital of Guangxi Medical University
RECRUITINGNanning, Guangxi, 530012, China
-
Anhui Provincial Hospital
RECRUITINGHefei, Anhui, 230002, China
-
Anyang Tumor Hospital
RECRUITINGAnyang, Henan, 455001, China
-
First Affiliated Hospital of Gannan Medical University
RECRUITINGGanzhou, Jiangxi, 341099, China
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, 450000, China
-
Jilin Guowen Hospital
RECRUITINGGongzhuling, Jilin, 130028, China
-
Lishui Central Hospital
RECRUITINGLishui, Zhejiang, 323020, China
-
Peking University First Hospital
RECRUITINGBeijing, Beijing Municipality, 100034, China
-
Shanxi Bethune Hospital
RECRUITINGTaiyuan, Shanxi, '030032, China
-
The Affiliated Cancer Hospital of Guizhou Medical University
RECRUITINGGuiyang, Guizhou, 550008, China
-
The First Affiliated Hospital of Henan University of Science & Technology
RECRUITINGLuoyang, Henan, 471023, China
-
The First Affiliated Hospital of Wenzhou Medical University
RECRUITINGWenzhou, Zhejiang, 325000, China
-
The Fourth Hospital of Hebei Medical University (Hebei Provincial Cancer Hospital)
RECRUITINGShijiazhuang, Hebei, '050010, China
-
The Second Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330008, China
-
Yichang Central People's Hospital
RECRUITINGYichang, Hubei, 443008, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- A new test could reveal how radiation affects the liver
- Can an immunotherapy drug keep liver cancer at bay after surgery?